| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 6.09e-05 | 507 | 54 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 6.09e-05 | 507 | 54 | 8 | GO:0030695 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.96e-04 | 231 | 54 | 5 | GO:0005085 | |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 8.42e-06 | 108 | 53 | 5 | GO:1902017 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 7.97e-05 | 280 | 53 | 6 | GO:1902115 | |
| GeneOntologyBiologicalProcess | actin filament-based process | AKAP6 AP1AR CCDC88A DSP INPP5K ARHGAP26 SPTBN1 SYNE2 CASQ1 ARHGEF2 | 9.39e-05 | 912 | 53 | 10 | GO:0030029 |
| GeneOntologyCellularComponent | Dsl1/NZR complex | 2.04e-05 | 3 | 55 | 2 | GO:0070939 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 2.26e-04 | 45 | 55 | 3 | GO:0033017 | |
| Domain | Spectrin/alpha-actinin | 2.88e-08 | 32 | 53 | 5 | IPR018159 | |
| Domain | SPEC | 2.88e-08 | 32 | 53 | 5 | SM00150 | |
| Domain | Spectrin_repeat | 1.30e-06 | 29 | 53 | 4 | IPR002017 | |
| Domain | Actinin_actin-bd_CS | 3.67e-05 | 23 | 53 | 3 | IPR001589 | |
| Domain | Spectrin | 3.67e-05 | 23 | 53 | 3 | PF00435 | |
| Domain | ACTININ_2 | 3.67e-05 | 23 | 53 | 3 | PS00020 | |
| Domain | ACTININ_1 | 3.67e-05 | 23 | 53 | 3 | PS00019 | |
| Domain | - | 1.18e-04 | 6 | 53 | 2 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 1.64e-04 | 7 | 53 | 2 | IPR001101 | |
| Domain | Plectin | 1.64e-04 | 7 | 53 | 2 | PF00681 | |
| Domain | PLEC | 1.64e-04 | 7 | 53 | 2 | SM00250 | |
| Domain | CH | 8.32e-04 | 65 | 53 | 3 | SM00033 | |
| Domain | CH | 1.03e-03 | 70 | 53 | 3 | PF00307 | |
| Domain | - | 1.08e-03 | 71 | 53 | 3 | 1.10.418.10 | |
| Domain | CH | 1.17e-03 | 73 | 53 | 3 | PS50021 | |
| Domain | RUN | 1.17e-03 | 18 | 53 | 2 | SM00593 | |
| Domain | CH-domain | 1.26e-03 | 75 | 53 | 3 | IPR001715 | |
| Domain | RUN | 1.31e-03 | 19 | 53 | 2 | PS50826 | |
| Domain | RUN | 1.31e-03 | 19 | 53 | 2 | PF02759 | |
| Domain | Run_dom | 1.31e-03 | 19 | 53 | 2 | IPR004012 | |
| Domain | SANT_dom | 2.46e-03 | 26 | 53 | 2 | IPR017884 | |
| Domain | SANT | 2.85e-03 | 28 | 53 | 2 | PS51293 | |
| Domain | PH | 4.03e-03 | 229 | 53 | 4 | PF00169 | |
| Domain | Myb_DNA-binding | 4.43e-03 | 35 | 53 | 2 | PF00249 | |
| Domain | MYB_LIKE | 5.20e-03 | 38 | 53 | 2 | PS50090 | |
| Domain | SET | 7.55e-03 | 46 | 53 | 2 | SM00317 | |
| Domain | PH | 7.94e-03 | 278 | 53 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 8.04e-03 | 279 | 53 | 4 | PS50003 | |
| Domain | PH_domain | 8.14e-03 | 280 | 53 | 4 | IPR001849 | |
| Domain | SET_dom | 8.87e-03 | 50 | 53 | 2 | IPR001214 | |
| Domain | SANT | 8.87e-03 | 50 | 53 | 2 | SM00717 | |
| Domain | SET | 8.87e-03 | 50 | 53 | 2 | PS50280 | |
| Domain | SANT/Myb | 9.57e-03 | 52 | 53 | 2 | IPR001005 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 2.42e-04 | 42 | 41 | 3 | M41826 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 2.42e-04 | 42 | 41 | 3 | M41828 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 2.42e-04 | 42 | 41 | 3 | MM15677 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.43e-04 | 439 | 41 | 7 | MM15595 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 2.60e-04 | 43 | 41 | 3 | MM15679 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.83e-04 | 450 | 41 | 7 | M27078 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.98e-04 | 45 | 41 | 3 | M39571 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 4.79e-04 | 649 | 41 | 8 | MM15690 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 9.49e-04 | 720 | 41 | 8 | M41838 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MTA2 NCOR2 DST SZT2 PLEKHM2 ARHGAP26 ANKLE1 REV3L ARHGEF2 HCFC1 RIC1 MADD | 1.53e-07 | 1105 | 56 | 12 | 35748872 |
| Pubmed | 4.61e-06 | 151 | 56 | 5 | 17043677 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 17699596 | ||
| Pubmed | 1.48e-05 | 497 | 56 | 7 | 23414517 | ||
| Pubmed | RINT-1 regulates the localization and entry of ZW10 to the syntaxin 18 complex. | 1.52e-05 | 4 | 56 | 2 | 16571679 | |
| Pubmed | 1.62e-05 | 504 | 56 | 7 | 34432599 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 20462495 | ||
| Pubmed | Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex. | 2.54e-05 | 5 | 56 | 2 | 11509665 | |
| Pubmed | 3.46e-05 | 568 | 56 | 7 | 37774976 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 11404076 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 19369418 | ||
| Pubmed | 4.23e-05 | 1049 | 56 | 9 | 27880917 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.75e-05 | 123 | 56 | 4 | 26912792 | |
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 24056303 | ||
| Pubmed | Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. | 5.32e-05 | 7 | 56 | 2 | 15272311 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MTA2 NCOR2 SERPINB6 DST DSP SPTBN1 DDX51 UBXN1 ARHGEF2 SRBD1 | 5.35e-05 | 1353 | 56 | 10 | 29467282 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 6.57e-05 | 857 | 56 | 8 | 25609649 | |
| Pubmed | 8.08e-05 | 650 | 56 | 7 | 38777146 | ||
| Pubmed | 8.32e-05 | 653 | 56 | 7 | 22586326 | ||
| Pubmed | 8.64e-05 | 657 | 56 | 7 | 36180527 | ||
| Pubmed | 8.98e-05 | 1440 | 56 | 10 | 30833792 | ||
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 12482924 | ||
| Pubmed | 9.48e-05 | 147 | 56 | 4 | 16959763 | ||
| Pubmed | Implication of ZW10 in membrane trafficking between the endoplasmic reticulum and Golgi. | 1.14e-04 | 10 | 56 | 2 | 15029241 | |
| Pubmed | Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. | 1.39e-04 | 11 | 56 | 2 | 11331609 | |
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 23658227 | ||
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 12802069 | ||
| Pubmed | 1.47e-04 | 963 | 56 | 8 | 28671696 | ||
| Pubmed | 1.55e-04 | 167 | 56 | 4 | 25659891 | ||
| Pubmed | The Rab7 effector PLEKHM1 binds Arl8b to promote cargo traffic to lysosomes. | 1.96e-04 | 13 | 56 | 2 | 28325809 | |
| Pubmed | 2.07e-04 | 1293 | 56 | 9 | 15342556 | ||
| Pubmed | 2.20e-04 | 340 | 56 | 5 | 24332808 | ||
| Pubmed | ZW10 links mitotic checkpoint signaling to the structural kinetochore. | 2.29e-04 | 14 | 56 | 2 | 15824131 | |
| Pubmed | 2.29e-04 | 14 | 56 | 2 | 16452088 | ||
| Pubmed | 2.29e-04 | 14 | 56 | 2 | 10575223 | ||
| Pubmed | The REV7 subunit of DNA polymerase ζ is essential for primordial germ cell maintenance in the mouse. | 3.01e-04 | 16 | 56 | 2 | 23463509 | |
| Pubmed | Spatiotemporal regulation of GLI target genes in the mammalian limb bud. | 3.51e-04 | 207 | 56 | 4 | 26238476 | |
| Pubmed | 3.81e-04 | 87 | 56 | 3 | 12465718 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 4.49e-04 | 92 | 56 | 3 | 15840729 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 4.49e-04 | 861 | 56 | 7 | 36931259 | |
| Pubmed | 4.58e-04 | 222 | 56 | 4 | 37071664 | ||
| Pubmed | 4.61e-04 | 1442 | 56 | 9 | 35575683 | ||
| Pubmed | 4.75e-04 | 20 | 56 | 2 | 27773593 | ||
| Pubmed | 4.75e-04 | 20 | 56 | 2 | 11707078 | ||
| Pubmed | 5.55e-04 | 638 | 56 | 6 | 31182584 | ||
| Pubmed | 5.58e-04 | 234 | 56 | 4 | 36243803 | ||
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 24337118 | ||
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 21670149 | ||
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | 7.13e-04 | 931 | 56 | 7 | 27432908 | |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 7.46e-04 | 25 | 56 | 2 | 30309841 | |
| Pubmed | Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. | 7.46e-04 | 25 | 56 | 2 | 19898481 | |
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 8.07e-04 | 26 | 56 | 2 | 30923192 | |
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 8.71e-04 | 27 | 56 | 2 | 23395962 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 9.72e-04 | 120 | 56 | 3 | 31413325 | |
| Pubmed | 9.98e-04 | 1285 | 56 | 8 | 35914814 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.00e-03 | 475 | 56 | 5 | 31040226 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.04e-03 | 1294 | 56 | 8 | 30804502 | |
| Pubmed | 1.08e-03 | 30 | 56 | 2 | 30480076 | ||
| Pubmed | 1.11e-03 | 486 | 56 | 5 | 20936779 | ||
| Pubmed | 1.15e-03 | 284 | 56 | 4 | 29459677 | ||
| Pubmed | 1.15e-03 | 31 | 56 | 2 | 33777788 | ||
| Pubmed | 1.20e-03 | 129 | 56 | 3 | 23022380 | ||
| Pubmed | 1.38e-03 | 299 | 56 | 4 | 37931956 | ||
| Pubmed | 1.46e-03 | 35 | 56 | 2 | 22325351 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 1.48e-03 | 1367 | 56 | 8 | 32687490 | |
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 1.58e-03 | 142 | 56 | 3 | 11812828 | |
| Cytoband | 9p24.1 | 8.00e-04 | 34 | 56 | 2 | 9p24.1 | |
| Cytoband | 8p23.1 | 9.01e-04 | 154 | 56 | 3 | 8p23.1 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.54e-05 | 8 | 34 | 2 | 939 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 4.59e-04 | 17 | 34 | 2 | 1197 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.00e-03 | 718 | 34 | 6 | 28 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.97e-03 | 50 | 34 | 2 | 721 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.45e-03 | 53 | 34 | 2 | 532 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.73e-03 | 206 | 34 | 3 | 682 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 2.39e-06 | 191 | 53 | 6 | M40019 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_345_5P_GENES | 2.10e-05 | 80 | 53 | 4 | MM17502 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 5.12e-05 | 199 | 53 | 5 | M6443 | |
| Coexpression | GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN | 5.12e-05 | 199 | 53 | 5 | M9543 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 5.24e-05 | 200 | 53 | 5 | M9354 | |
| Coexpression | GSE17721_CTRL_VS_LPS_4H_BMDC_UP | 5.24e-05 | 200 | 53 | 5 | M3689 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.49e-05 | 125 | 53 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 4.81e-07 | 123 | 56 | 5 | 967f20fcb27c9989de93f4183038334105910175 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-Treg-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-06 | 190 | 56 | 5 | c3c7de22657a86495939456bc22eac61c93db8b2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-Treg|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-06 | 190 | 56 | 5 | 166119c037d80fee852567a9cc53c4143dd19037 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-06 | 198 | 56 | 5 | 9ce9b3721fb8a154667211c29e60133412134c76 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-06 | 198 | 56 | 5 | 3c23fb8a84d4e4a20f7fa60055c7b37fc45a29d5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.22e-05 | 154 | 56 | 4 | 89c9c9918af32f3952790b41f1471b2c80ffce2f | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_CTL|Leuk-UTI / Disease, Lineage and Cell Type | 4.22e-05 | 154 | 56 | 4 | 170a421fd69dba2929568c72e983ae9cfaf2aabc | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_CTL|URO / Disease, Lineage and Cell Type | 5.14e-05 | 162 | 56 | 4 | 1afeeb17e263cf625a4f285203cf82f973735193 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 6.06e-05 | 169 | 56 | 4 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | Healthy_Control-Lymphoid-T-Treg|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 7.09e-05 | 176 | 56 | 4 | 7765a5b04ac117d525201f8eb08e1754e55942ff | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.25e-05 | 183 | 56 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.42e-05 | 184 | 56 | 4 | 08bff25390e3484b75c860738396a405141b69fd | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 8.60e-05 | 185 | 56 | 4 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | IPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 8.60e-05 | 185 | 56 | 4 | 77fbecdab10bacc005b1c7e22ca414cfecef13c1 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.60e-05 | 185 | 56 | 4 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.60e-05 | 185 | 56 | 4 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.96e-05 | 187 | 56 | 4 | 9fdfca5b70f585843ef9d810154674a8e561e765 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.96e-05 | 187 | 56 | 4 | a525753a8a908ee1ef0b8f06e68855e4af27bf86 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD4_TCM|Int-URO / Disease, Lineage and Cell Type | 8.96e-05 | 187 | 56 | 4 | 9a137961d33c6b440f1e5ef40360a365e3c03ab2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.15e-05 | 188 | 56 | 4 | 34873972dff9284dfcd26bb698c9d1df007f1cbb | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 9.53e-05 | 190 | 56 | 4 | 5f8d606d2f465ddeae7451835f84b3f25a151d2a | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 9.53e-05 | 190 | 56 | 4 | 519356c4925b5b6647e7d763d4084cd9b2e94f0a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 191 | 56 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 191 | 56 | 4 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 191 | 56 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 191 | 56 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Healthy-Treg|World / disease group, cell group and cell class | 1.01e-04 | 193 | 56 | 4 | e22bfcd170ba23e313512f0f07c658fcf6ae1b97 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease, Lineage and Cell Type | 1.05e-04 | 195 | 56 | 4 | 35b2fe0588877d30cbd5d3ae259fcfd959907429 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.05e-04 | 195 | 56 | 4 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.07e-04 | 196 | 56 | 4 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.07e-04 | 196 | 56 | 4 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 197 | 56 | 4 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_CTL|URO / Disease, condition lineage and cell class | 1.12e-04 | 198 | 56 | 4 | c53405a8d082fbd10131a6ec88b69fdd835f2925 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.14e-04 | 199 | 56 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 1.14e-04 | 199 | 56 | 4 | 22a16381ad68e758aa8e44fa0d6d5a2335aa5fe3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.16e-04 | 200 | 56 | 4 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_Tcm|Int-URO / Disease, condition lineage and cell class | 1.16e-04 | 200 | 56 | 4 | 848d1f9ae79dc9d012c89fcd5cf8f2f1a7ef8e13 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-Treg|Int-URO / Disease, condition lineage and cell class | 1.16e-04 | 200 | 56 | 4 | 47f265336bc3b8052c0cac730ac9afd41cd8fc43 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_Tcm|URO / Disease, condition lineage and cell class | 1.16e-04 | 200 | 56 | 4 | 4689fd4c6e7f078d7e91783a1646dd85c03cba77 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; HL60; HT_HG-U133A | 5.68e-06 | 197 | 52 | 6 | 3056_DN | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 5.85e-06 | 198 | 52 | 6 | 4621_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A | 6.02e-06 | 199 | 52 | 6 | 4562_DN | |
| Drug | plakin | 3.71e-05 | 82 | 52 | 4 | CID000018752 | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 7.08e-05 | 189 | 52 | 5 | 6960_UP | |
| Drug | Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 3363_UP | |
| Drug | Imidurea [39236-46-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 3522_UP | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 5631_UP | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 6557_UP | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 1821_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 5253_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 4538_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 4423_DN | |
| Drug | 3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 6367_DN | |
| Drug | Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 6774_UP | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; HL60; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 2133_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 4134_UP | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 2327_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 6603_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 6652_UP | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 6230_UP | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 5048_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 4537_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 5787_DN | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A | 9.25e-05 | 200 | 52 | 5 | 5284_DN | |
| Disease | Hirschsprung disease | 6.02e-04 | 21 | 51 | 2 | MONDO_0018309 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASDMLHMRWDEELAA | 51 | Q6UXB8 | |
| SVSAEETEKWMEEAM | 16 | Q7Z6V5 | |
| SIDSDMATLWLTEDE | 326 | Q8NAG6 | |
| LVSEEDMVTVVEDWM | 31 | Q9NZD4 | |
| DIVENWSVEEQAMEM | 1781 | Q9UIF8 | |
| WSVEEQAMEMDLSVL | 1786 | Q9UIF8 | |
| EMDEKDFAADSWSLA | 206 | Q92974 | |
| LDLEWEDEEGMNRML | 206 | Q63HQ0 | |
| AEMEEALLEWGTLAM | 1521 | Q96M86 | |
| EMVMVDSEGSLSVWN | 1156 | Q9ULI1 | |
| CRDEMEEWSASEAML | 261 | O94776 | |
| EEWSASEAMLFEEAL | 266 | O94776 | |
| SDMDFMVDESGLWAV | 321 | O95897 | |
| SSMVDGDWTMVDENF | 1221 | Q4ADV7 | |
| LEMSTNWGEDMTSVD | 416 | Q8TE59 | |
| LDTMAWETILMDTLE | 301 | P51610 | |
| SMELNESSRWTEEEM | 606 | Q9Y618 | |
| MWDQLEDAAMETFSI | 1296 | Q8WXG6 | |
| LDEMLDWMGNVESSL | 4166 | Q03001 | |
| MEPWAMRALDFADES | 1 | Q86SG4 | |
| FDLQWMEVTDMSQED | 171 | Q3V6T2 | |
| ESLMGEVATDWMDTE | 1711 | Q9UM47 | |
| EEELTQMVSTMSDGW | 151 | Q8N5Z5 | |
| SEATLMAWSSMDGED | 136 | Q86XD5 | |
| LTALDEETLWEMMES | 11 | Q9BXL6 | |
| DEADRMIDSMHQSWL | 371 | Q8N8A6 | |
| VTDADSVWMEMDDEE | 351 | P31415 | |
| SVWMEMDDEEDLPSA | 356 | P31415 | |
| EMDMVAWGVDLASVE | 201 | P15924 | |
| EDLWTVENDMMVSYS | 336 | Q9BT40 | |
| SLQGREWTLMDLDME | 401 | Q9ULV5 | |
| EWNDVLSEMTLMDVD | 136 | A6NE01 | |
| DEEMENEICRVWDMS | 66 | Q96ER3 | |
| VWDMSMDEDVALFLQ | 76 | Q96ER3 | |
| LELSAESEAEMAEWM | 851 | Q8IWE5 | |
| DMEAMLDTVQAWLSS | 61 | Q9NPI5 | |
| ETTMNEIRWLLEDEM | 1691 | Q5T011 | |
| SSDLFEEWMGALEMQ | 171 | Q8N103 | |
| EDWEINKDSAVEMAM | 2401 | Q8WXH0 | |
| MAEDGSEEIMFIWCE | 301 | P57071 | |
| ALSEEDRRLWMEAMD | 351 | Q9UNA1 | |
| EEEDAFWMMSAIIED | 216 | Q96HU1 | |
| WTRLDMMDEEEVEVS | 256 | P35237 | |
| MEDADMTLWTEAEFE | 41 | O75626 | |
| MEEMVEDSVDCYWIT | 141 | Q9P0N9 | |
| ILAMMVDLQDDEDWV | 316 | O60518 | |
| EEVEMNWDMVQVLSE | 206 | Q8N5C6 | |
| AAEAEAWMSEQELYM | 1601 | Q01082 | |
| LWDWLIDMESLVMDS | 971 | Q13023 | |
| LMDLNGMSEDALEWD | 1206 | Q13023 | |
| GMSEDALEWDEMDIS | 1211 | Q13023 | |
| EQMESEDMLSALGWS | 56 | Q9C0C6 | |
| DVAIDFTQEEWAMMD | 11 | Q6ZN79 | |
| EEMELSLVMSQRWDS | 461 | O60673 | |
| WMDDLGTMISQIEEI | 141 | Q6NUQ1 | |
| DVAIDFTQEEWAMMD | 11 | A8MWA4 | |
| DVAIDFTQEEWAMMD | 11 | A8MUZ8 | |
| GIEAAMDWLMEHEDD | 31 | Q04323 | |
| DVAIDFTQEEWDMMD | 11 | P0CI00 | |
| DVAIDFTQEEWDMMD | 11 | P0CH99 | |
| EDDEDMTLTRWTGMI | 36 | Q15819 | |
| LAEMLGDMIWEDLSE | 326 | O43264 |